5-1-2020 Update
In today’s update, I share the status of our COVID-19 drug treatment play, the impending food supply-chain disruption and the Fed’s projections for 2020 GDP as well as my plans for how we’ll use these opportunities to our advantage.
Watch as I discuss the imminent shortage in food processing capacity and how I believe this under-appreciated event, along with the Fed’s big miss on Weekly Economic Indicators, will affect our investment strategy.
And a big congratulations to our members participating in our virus drug treatment trade who are riding a solid 50% gain in just a couple of weeks. We’ll continue to hold this under-the-radar stock while we wait for the mainstream to catch on, offering a chance to book triple-digit gains (or more).